Evolysse Form and Smooth Injectable HA Gels Hit Market
Evolus launched its Evolysse Form and Evolysse Smooth injectable HA gels on April 18, following a national webcast and early access program involving over 1,000 aesthetic practices.
Evolus launched its Evolysse Form and Evolysse Smooth injectable HA gels on April 18, following a national webcast and early access program involving over 1,000 aesthetic practices.
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.